Significant Incidental Findings in the National Lung Screening Trial.

Importance Low-dose computed tomography (LDCT) lung screening has been shown to reduce lung cancer mortality. Significant incidental findings (SIFs) have been widely reported in patients undergoing LDCT lung screening. However, the exact nature of these SIF findings has not been described. Objective To describe SIFs reported in the LDCT arm of the National Lung Screening Trial and classify SIFs as reportable or not reportable to the referring clinician (RC) using the American College of Radiology's white papers on incidental findings. Design, Setting, and Participants This was a retrospective case series study of 26 455 participants in the National Lung Screening Trial who underwent at least 1 screening examination with LDCT. The trial was conducted from 2002 to 2009, and data were collected at 33 US academic medical centers. Main Outcomes and Measures Significant incident findings were defined as a final diagnosis of a negative screen result with significant abnormalities that were not suspicious for lung cancer or a positive screen result with emphysema, significant cardiovascular abnormality, or significant abnormality above or below the diaphragm. Results Of 26 455 participants, 10 833 (41.0%) were women, the mean (SD) age was 61.4 (5.0) years, and there were 1179 (4.5%) Black, 470 (1.8%) Hispanic/Latino, and 24 123 (91.2%) White individuals. Participants were scheduled to undergo 3 screenings during the course of the trial; the present study included 75 126 LDCT screening examinations performed for 26 455 participants. A SIF was reported for 8954 (33.8%) of 26 455 participants who were screened with LDCT. Of screening tests with a SIF detected, 12 228 (89.1%) had a SIF considered reportable to the RC, with a higher proportion of reportable SIFs among those with a positive screen result for lung cancer (7632 [94.1%]) compared with those with a negative screen result (4596 [81.8%]). The most common SIFs reported included emphysema (8677 [43.0%] of 20 156 SIFs reported), coronary artery calcium (2432 [12.1%]), and masses or suspicious lesions (1493 [7.4%]). Masses included kidney (647 [3.2%]), liver (420 [2.1%]), adrenal (265 [1.3%]), and breast (161 [0.8%]) abnormalities. Classification was based on free-text comments; 2205 of 13 299 comments (16.6%) could not be classified. The hierarchical reporting of final diagnosis in NLST may have been associated with an overestimate of severe emphysema in participants with a positive screen result for lung cancer. Conclusions and Relevance This case series study found that SIFs were commonly reported in the LDCT arm of the National Lung Screening Trial, and most of these SIFs were considered reportable to the RC and likely to require follow-up. Future screening trials should standardize SIF reporting.

[1]  E. Kazerooni,et al.  A Quick Reference Guide for Incidental Findings on Lung Cancer Screening CT Examinations. , 2022, Journal of the American College of Radiology : JACR.

[2]  G. Michaud,et al.  Standardizing the Reporting of Incidental, Non-Lung Cancer (Category S) Findings Identified on Lung Cancer Screening Low Dose Computed Tomography. , 2022, Chest.

[3]  P. Pinsky,et al.  Incidental Findings on Low-Dose CT Lung Cancer Screenings and Deaths from Respiratory Diseases. , 2021, Chest.

[4]  M. Cabana,et al.  Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[5]  L. Henderson,et al.  Cardiovascular Risk in the Lung Cancer Screening Population: A Multicenter Study Evaluating the Association Between Coronary Artery Calcification and Preventive Statin Prescription. , 2021, Journal of the American College of Radiology : JACR.

[6]  A. Fendrick,et al.  Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018 , 2021, JAMA network open.

[7]  C. Berg,et al.  Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines. , 2021, Journal of the National Cancer Institute.

[8]  S. J. Henley,et al.  Screening for Lung Cancer — 10 States, 2017 , 2020, MMWR. Morbidity and mortality weekly report.

[9]  Harry J de Koning,et al.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.

[10]  A. Begnaud,et al.  Incidental Findings in a Decentralized Lung Cancer Screening Program. , 2019, Annals of the American Thoracic Society.

[11]  J. Huo,et al.  Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting , 2019, JAMA internal medicine.

[12]  M. Budoff,et al.  Coronary Artery Calcium Scores and Atherosclerotic Cardiovascular Disease Risk Stratification in Smokers. , 2018, JACC. Cardiovascular imaging.

[13]  J. Yeboah.  Lung Cancer Screening Eligible? , 2018, Circulation.

[14]  H. Macmahon,et al.  Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings Committee. , 2018, Journal of the American College of Radiology : JACR.

[15]  R. Munden,et al.  Incidental Findings on Lung Cancer Screening: Significance and Management. , 2018, Seminars in ultrasound, CT, and MR.

[16]  T. Tosteson,et al.  Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings , 2018, Medical care.

[17]  S. Silverman,et al.  Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee. , 2017, Journal of the American College of Radiology : JACR.

[18]  E. Fishman,et al.  Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee. , 2017, Journal of the American College of Radiology : JACR.

[19]  P. Mazzone,et al.  Frequency of Incidental Findings and Subsequent Evaluation in Low‐Dose Computed Tomographic Scans for Lung Cancer Screening , 2017, Annals of the American Thoracic Society.

[20]  G. Israel,et al.  Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. , 2017, Journal of the American College of Radiology : JACR.

[21]  D. Sahani,et al.  Management of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings Committee. , 2017, Journal of the American College of Radiology : JACR.

[22]  B. Kramer,et al.  Incidental renal tumours on low-dose CT lung cancer screening exams , 2017, Journal of medical screening.

[23]  Sritha Rajupet,et al.  Attitudes About Lung Cancer Screening: Primary Care Providers Versus Specialists , 2017, Clinical lung cancer.

[24]  J. Eastwood,et al.  Extrapulmonary Findings and Malignancies in Participants Screened With Chest CT in the National Lung Screening Trial. , 2017, Journal of the American College of Radiology : JACR.

[25]  A. Stillman,et al.  The Dubious Value of Coronary Calcium Scoring on Lung Cancer Screening CT. , 2017, Journal of the American College of Radiology : JACR.

[26]  S. Datta,et al.  Implementation of Lung Cancer Screening in the Veterans Health Administration , 2017, JAMA internal medicine.

[27]  J. Rathmell,et al.  Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? , 2016, Clinical trials.

[28]  M. Kegler,et al.  Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening , 2015, Cancer.

[29]  T. Wilt,et al.  A value framework for cancer screening: advice for high-value care from the American College of Physicians. , 2015, Annals of internal medicine.

[30]  Scott G. Baginski,et al.  Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. , 2015, Radiology.

[31]  Carol C Wu,et al.  Managing incidental thyroid nodules detected on imaging: white paper of the ACR Incidental Thyroid Findings Committee. , 2015, Journal of the American College of Radiology : JACR.

[32]  Arash Naeim,et al.  Cost-effectiveness of CT screening in the National Lung Screening Trial. , 2014, The New England journal of medicine.

[33]  V. Moyer.  Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[34]  N. Paul,et al.  Beyond Lung Cancer: A Strategic Approach to Interpreting Screening Computed Tomography Scans on the Basis of Mortality Data From the National Lung Screening Trial , 2013, Journal of thoracic imaging.

[35]  I. Gareen,et al.  Identifying and collecting pertinent medical records for centralized abstraction in a multi-center randomized clinical trial: the model used by the American College of Radiology arm of the National Lung Screening Trial. , 2013, Contemporary clinical trials.

[36]  Linda Humphrey,et al.  Appropriate Use of Screening and Diagnostic Tests to Foster High-Value, Cost-Conscious Care , 2012, Annals of Internal Medicine.

[37]  G. Veronesi,et al.  Extrapulmonary malignancies detected at lung cancer screening. , 2011, Radiology.

[38]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[39]  Douglas K Owens,et al.  High-Value, Cost-Conscious Health Care: Concepts for Clinicians to Evaluate the Benefits, Harms, and Costs of Medical Interventions , 2011, Annals of Internal Medicine.

[40]  D. Lynch,et al.  The National Lung Screening Trial: overview and study design. , 2011, Radiology.

[41]  Denise R. Aberle,et al.  Baseline Characteristics of Participants in the Randomized National Lung Screening Trial , 2010, Journal of the National Cancer Institute.

[42]  M. Oudkerk,et al.  Neglectable benefit of searching for incidental findings in the Dutch--Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT , 2007, European Radiology.

[43]  G. McVey,et al.  Screening for lung cancer using low dose CT scanning: results of 2 year follow up , 2005, Thorax.

[44]  S. Swensen,et al.  Screening for lung cancer with low-dose spiral computed tomography. , 2000, American journal of respiratory and critical care medicine.

[45]  Translational Lung Cancer Research , 2022 .